Compare SCNX & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCNX | NRT |
|---|---|---|
| Founded | 2010 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 81.0M |
| IPO Year | 2019 | 1995 |
| Metric | SCNX | NRT |
|---|---|---|
| Price | $3.23 | $6.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 49.6K | 20.5K |
| Earning Date | 11-12-2026 | 09-08-2026 |
| Dividend Yield | N/A | ★ 9.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | ★ $3,831,778.00 | N/A |
| Revenue This Year | $743.36 | N/A |
| Revenue Next Year | $325.03 | N/A |
| P/E Ratio | ★ N/A | $11.99 |
| Revenue Growth | ★ 30.72 | N/A |
| 52 Week Low | $2.64 | $5.52 |
| 52 Week High | $106.25 | $10.49 |
| Indicator | SCNX | NRT |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 22.01 |
| Support Level | $2.64 | $6.87 |
| Resistance Level | $10.60 | $8.74 |
| Average True Range (ATR) | 0.32 | 0.34 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 49.61 | 15.88 |
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.